asset,query,published_at_utc,title,summary,url,source
Pfizer,Pfizer,2025-10-01T05:19:28Z,Pfizer Cuts U.S. Drug Prices Under Trump Pressure - 조선일보,,https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb1FqTHQ5RmhLMVI1czJfaHlWOVdqQnRFeVFtTzh6TkxoM0JHUER1V2t2Z3NGR3ZIYWRYSzJpZmVZT1N1SXNwM3c5XzladFhOUEd4TXU3M0tjZG1lazdSaHNaYXRNaEFuZ0dqam9jSmFzakxVaEdfbUNTenlzQ25LZzV5enNiaDZB?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-01T05:11:30Z,Novo Nordisk retreats from heart failure cell therapy collaboration - FirstWord Pharma,,https://news.google.com/rss/articles/CBMiU0FVX3lxTE9VVnpFTlR5YVVaa0FtcWdORXgzckRycWdEQ3dGMXBHNDdFbXNWUG1aSlNuZ0pheXFxb1VYOUV1RFU5OWpCdFhXcXc1cUVuT3l6WGJV?oc=5,gnews
Pfizer,Pfizer,2025-10-01T05:01:54Z,Pfizer Announces $70 Billion U.S. Investment and Drug Pricing Parity Agreement with Trump Administration - geneonline.com,,https://news.google.com/rss/articles/CBMiygFBVV95cUxOZUFpU2NLaVRiTU5PeFR2NVBPcFA2M1M2R0RvVkZIbExIaHl2V2NtMnduOXRBeHRYUjA4RHU3a3pCTHpabTZCWFRVdWR3b09NdGxlNWk3Z2JmRW1OWmt0aDlkcnlQT1FYMWZkbjBBZ3pzdE1CMlRGOG94S0ZqUVYxN2xfRnVJOEpKYzRsb0FncW5xdDMtWXdnR2ZKNU5GM2FkYkVoeDhrMVgyNGxMaTMyZGhNMF94TWZ1d0QtTklqSEZ1T1hEVG5ZS013?oc=5,gnews
Pfizer,Pfizer,2025-10-01T05:01:33Z,Trump RX Deal: Pfizer to Supply Medicaid Drugs at European Prices - Meyka,,https://news.google.com/rss/articles/CBMimAFBVV95cUxORUJBQzFMTE5naHE0cUpLNnVOcl81ZXNrd3M1LUx3Njk2M1ktUk1rYlE0VktOOHVadkZvZXkyQUNzM28yVEljVUlRYmJxcENZTXVmajFPU2h2T3E5RUNzNE5xNEZ6WGlRdm5kaEV0TGZGQzNOVXZwX2I0U3hjaE15NTg3UnBrUTNHbEVoWVNTa3lfaFZ3X2NmMA?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-01T05:00:00Z,Novo Nordisk Investors Eye Alzheimer’s Trial for Glimmer of Hope - Bloomberg.com,,https://news.google.com/rss/articles/CBMitgFBVV95cUxOcWIzZ2R4SVNETTBRTmstRUxMZEk1dVdxTkRNTDNuUDJwWnF3TUpZejlhVlFCY2UyZXM4SzlZRUVscUJQaGgyMk02LVdiRmhKaEN2LXZaeU9JckhjY1J2NndhbU8wN1pHU2M0NndzQzNFWmRqNHlYWk9fdncyR01RREJvSGlWWml0YzlsU2dhcllUdlA4VGxSYVNYUzJuWndGVGRIRDFFNmR4b0ZIcmlKNkpoaWFaQQ?oc=5,gnews
Pfizer,Pfizer,2025-10-01T04:59:57Z,"Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground - MSN",,https://news.google.com/rss/articles/CBMigwJBVV95cUxQeS1INElacW8wLXBlZ2U1WENSNEF6Wmswd0tCTDdvaFNmdk5wNkg2VlhZTDNNaEJuN2M5SW9lVnFwOE1OLVR0SFJERU5oc0lYLXpZUnUwUUFlaUhpbHhzVGJ5Q2xCWS1vbmcxNXJvWUJvZ19SRGZqYzVTejJzTUtVVmRhZ0tLa2NPOGRyeUl2UEJ2QkVIVTlGaGFIN1R1aldOOWQwU2J2MXRxWmczZTJRbE1UOVA3aDZHMkF2OUxVLS1yV2psekFMU19mZElRUGQ1b01VcFNEMWg1Sm9lem5YcFl6OXR1b2NQemE4aGt0a2otVVo5SVVqZngxbVdIdldhb0pF?oc=5,gnews
